The lone patient with a grade 2 tumor with over 30% homozygous deletion in our study is still alive at 61 months from diagnosis, and neither of the above array-based studies identified any histologic grade 2 tumors with CDKN2A homozygous deletion (Shirahat et al. Here, CDKN2A is linked to neoplasm.